Author:
Sitarz Jamie,Spencer Cara
Publisher
Oncology Nursing Society (ONS)
Reference23 articles.
1. Bitto, F.F., König, A., Phan-Brehm, T., Vallbracht, T., Koch, J.G., Schinköthe, T., . . . Würstlein, R. (2020). EVA-Scalp: Evaluation of patient satisfaction with a scalp cooling device to prevent chemotherapy-induced alopecia in breast cancer patients. Breast Care, 15(2), 171–177. https://doi.org/10.1159/000501393
2. Boland, V., Brady, A.M., & Drury, A. (2020). The physical, psychological and social experiences of alopecia among women receiving chemotherapy: An integrative literature review. European Journal of Oncology Nursing, 49, 101840. https://doi.org/10.1016/j.ejon.2020.101840
3. Chin, C.H., Tseng, L.M., Chao, T.C., Wang, T.J., Wu, S.F., & Liang, S.Y. (2021). Self-care as a mediator between symptom-management self-efficacy and quality of life in women with breast cancer. PLOS ONE, 16(2), e0246430. https://doi.org/10.1371/journal.pone.0246430
4. Dignicap. (2020). Contraindications and safety considerations. https://www.dignicap.com/professionals/contraindications
5. Dignicap Delta. (2019). The Dignicap Scalp Cooling System Training Guide (TR-20190801-04-US) [Training Guide].